Related Experiment Video
Updated: Oct 12, 2026

Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
Published on: March 23, 2016
Methodical design, development, and evaluation of transferosomal transdermal films for enhanced delivery of
Gopinath Subramaniyan1, Shaik Rubina2, Bachu Venkata Ramana3
1Department of Pharmaceutics, Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (DU), Chennai, India.
Aim:
The present work aimed to enhance systemic availability through optimized transferosomal transdermal films of lornoxicam (LXM) and thiocolchicoside (TCS). Transferosomes were prepared using the thin-film hydration method, in which LXM and TCS, which have low oral bioavailability and adverse effects, were loaded.
Methods:
A Box-Behnken design was used to develop 17 vesicles in which dipalmitoyl phosphatidylcholine (X1), Span-80 (X2), and sonication time (X3) were varied and assessed for size, polydispersity index , and entrapment efficiency. The best vesicles were made into films. Films were extensively tested for physical, in vivo, and in vitro permeation, and skin irritancy characteristics.
Results:
The findings revealed vesicle sizes of 124 ± 2.25 to 400 ± 1.55 nm and a zeta potential of -48 to -20 mV. The drug entrapment was more than 80% for both drugs. In vitro and ex vivo permeation showed that the deformable vesicle film permeated much better than plain LXM and TCS films, and the permeation was directly proportional to the Aloe vera leaf mucilage (AVLM) and lime oil (LO) concentration. Also, the deformable vesicle films were reported to be devoid of skin irritation.
Conclusion:
The research finds that deformable vesicle films of LXM/ TCS are promising for effective transdermal delivery.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Delivery Systems: Different Types
Modified-Release Drug Delivery Systems: Overview
Modified-Release Drug Delivery Systems: Site-Targeted
Oral Drug Delivery Systems: Continuous-Release Systems
Transdermal Drug Delivery Systems

